The article highlights Veterans, including our own Juliana Mercer, having transformative journeys and subsequently dedicating themselves to pursuing careers studying or advocating these new novel therapies.

The inclusion of an amendment directing the Department of Veterans Affairs to conduct a large-scale study in compounds that received FDA breakthrough status, like MDMA for PTSD, demonstrates a commitment to exploring innovative therapies. The unanimous passage of the amendment reflects congressional recognition of the potential revolutionary impact of psychedelic-assisted therapies on mental health treatment for veterans.

Read the article here.